2.

Relationship between MAGI1 protein expression and clinicopathological features in GC patients (N=58)

Clinicopathological features	Case No.	MAGI1 expression [n (%)]		χ²	P
Clinicopathological features	Case No.	Negative	Positive	χ²	P
MAGI1, membrane-associated guanylate kinase inverted 1; GC, gastric cancer; , Chi-square test; *, Kruskal-Wallis test.
Gender				0.330	0.566*
Male	32	22 (68.8)	10 (31.2)
Female	26	16 (61.5)	10 (38.5)
Age (year)				0.190	0.663*
≤60	37	25 (67.6)	12 (32.4)
>60	21	13 (61.9)	8 (38.1)
Lauren classification				9.005	0.003*
Intestinal/mixed	25	11 (44.0)	14 (56.0)
Diffused	33	27 (81.8)	6 (18.2)
Depth of invasion				0.074	0.786*
T1	10	5 (50.0)	5 (50.0)
T2-4	48	33 (68.8)	15 (31.2)
Lymph node status				1.288	0.256*
N0	10	5 (50.0)	5 (50.0)
N1-3	48	33 (68.8)	15 (31.3)
Distant metastasis				3.874	0.049*
M0	47	28 (59.6)	19 (40.4)
M1	11	10 (90.9)	1 (9.1)
TNM staging				6.012	0.111**
I	5	3 (60.0)	2 (40.0)
II	16	7 (43.8)	9 (56.2)
III	23	16 (69.6)	7 (30.4)
IV	14	12 (85.7)	2 (14.3)
Differentiation				11.914	0.008**
High-medium	2	1 (50.0)	1 (50.0)
Medium	8	1 (12.5)	7 (87.5)
Medium-low	7	5 (71.4)	2 (28.6)
Low	41	31 (75.6)	10 (24.4)